PE28191A1 - Procedimiento para la expresion del factor de crecimiento nervioso en celulas eucarioticas - Google Patents

Procedimiento para la expresion del factor de crecimiento nervioso en celulas eucarioticas

Info

Publication number
PE28191A1
PE28191A1 PE1990177640A PE17764090A PE28191A1 PE 28191 A1 PE28191 A1 PE 28191A1 PE 1990177640 A PE1990177640 A PE 1990177640A PE 17764090 A PE17764090 A PE 17764090A PE 28191 A1 PE28191 A1 PE 28191A1
Authority
PE
Peru
Prior art keywords
growth factor
expression
procedure
nervous growth
cells
Prior art date
Application number
PE1990177640A
Other languages
English (en)
Inventor
Valle Francesco Della
Alessandro Negro
Lanfranco Callegaro
Original Assignee
Fidia Spa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Fidia Spa filed Critical Fidia Spa
Publication of PE28191A1 publication Critical patent/PE28191A1/es

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09Recombinant DNA-technology
    • C12N15/11DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/475Growth factors; Growth regulators
    • C07K14/48Nerve growth factor [NGF]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/28Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Genetics & Genomics (AREA)
  • Biomedical Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Zoology (AREA)
  • Molecular Biology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Biochemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • General Chemical & Material Sciences (AREA)
  • Biophysics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biotechnology (AREA)
  • General Engineering & Computer Science (AREA)
  • Toxicology (AREA)
  • Wood Science & Technology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Plant Pathology (AREA)
  • Immunology (AREA)
  • Physics & Mathematics (AREA)
  • Hospice & Palliative Care (AREA)
  • Microbiology (AREA)
  • Psychiatry (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

CARACTERIZADO PORQUE SE OBTIENE DE LAS CELULAS TRANSFORMADAS EL POLIPEPTIDO DENOMINADO FACTOR DE CRECIMIENTO NERVIOSO (B-NGF) Y MAS PRECISAMENTE PORQUE SE OBTIENE, MEDIANTE LA TECNOLOGIA DEL ADN RECOMBINANTE A PARTIR DE CONSTRUCCIONES GENETICAS INSERTABLES EN APROPIADAS LINEAS CELULARES EUCARIOTICAS, LA FORMA MADURA HUMANA BIOLOGICAMENTE ACTIVA
PE1990177640A 1989-11-16 1990-11-15 Procedimiento para la expresion del factor de crecimiento nervioso en celulas eucarioticas PE28191A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IT04856489A IT1238348B (it) 1989-11-16 1989-11-16 Processo per la preparazione di costrutti genetici per l'espressione del fattore di crescita nervoso in cellule eucariote.

Publications (1)

Publication Number Publication Date
PE28191A1 true PE28191A1 (es) 1991-10-28

Family

ID=11267348

Family Applications (1)

Application Number Title Priority Date Filing Date
PE1990177640A PE28191A1 (es) 1989-11-16 1990-11-15 Procedimiento para la expresion del factor de crecimiento nervioso en celulas eucarioticas

Country Status (22)

Country Link
US (1) US5457034A (es)
EP (1) EP0432510B1 (es)
JP (2) JP3121611B2 (es)
KR (1) KR910009929A (es)
CN (1) CN1051934A (es)
AR (1) AR246983A1 (es)
AT (1) ATE214735T1 (es)
CA (1) CA2030108C (es)
DE (1) DE69033937T2 (es)
ES (1) ES2173856T3 (es)
FI (1) FI905691A (es)
HU (1) HUT61047A (es)
IE (1) IE904120A1 (es)
IL (1) IL96347A (es)
IT (1) IT1238348B (es)
NZ (1) NZ236058A (es)
PE (1) PE28191A1 (es)
PL (1) PL287811A1 (es)
PT (1) PT95911B (es)
TW (1) TW205069B (es)
YU (1) YU217890A (es)
ZA (1) ZA909122B (es)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5169762A (en) * 1983-03-03 1992-12-08 Genentech, Inc. Human nerve growth factor by recombinant technology
US6090781A (en) * 1996-11-06 2000-07-18 Genentech, Inc. Stabilizing formulation for NGF
US6964947B1 (en) * 1995-11-07 2005-11-15 Genentech, Inc. Stabilizing formulation for NGF
US6495662B1 (en) * 1998-10-22 2002-12-17 The General Hospital Corporation Bioactive peptides and peptide derivatives of parathyroid hormone (PTH) and parathyroid hormone-related peptide (PTHrP)
ES2316354T3 (es) 1999-09-29 2009-04-16 The General Hospital Corporation Derivados polipeptidos de la hormona paratiroidea (pth).
WO2001023521A2 (en) * 1999-09-29 2001-04-05 The General Hospital Corporation Polypeptide derivatives of parathyroid hormone (pth)
AU7907301A (en) * 2000-07-28 2002-02-13 Christopher J Murphy Transplant media
JP4837888B2 (ja) * 2001-07-23 2011-12-14 ザ ジェネラル ホスピタル コーポレイション コンホメーションが拘束された副甲状腺ホルモン(pth)類似体
EP1610813A4 (en) 2003-03-19 2009-07-01 Gen Hospital Corp PARATHYROIDAL HORMONES CONFORMALLY CONFORMALLY CONSTRAINED WITH PROPELLER STABILIZERS $ G (A)
WO2005009358A2 (en) 2003-07-17 2005-02-03 The General Hospital Corporation Conformationally constrained parathyroid hormone (pth) analogs
US20070207209A1 (en) * 2004-08-27 2007-09-06 Murphy Christopher J Trophic factor combinations for nervous system treatment
EP2054077A4 (en) * 2006-08-04 2010-10-13 Gen Hospital Corp POLYPEPTIDE DERIVATIVES OF PARATHYROID HORMONE (PTH)
CN101260398B (zh) * 2007-03-07 2013-06-05 舒泰神(北京)生物制药股份有限公司 神经生长因子基因定位改造动物及其制备方法和应用
CA2694667C (en) 2007-08-01 2018-10-30 The General Hospital Corporation Screening methods using g-protein coupled receptors and related compositions
CN101927012B (zh) * 2009-06-26 2013-08-14 丽珠医药集团股份有限公司 神经生长因子的病毒灭活方法
CN103002906B (zh) 2010-05-13 2017-12-29 总医院有限公司 甲状旁腺激素类似物及其应用
CN102816766A (zh) * 2012-05-04 2012-12-12 沈阳医学院 蛇毒神经生长因子活性多肽的筛选方法
CN114729330A (zh) * 2021-07-30 2022-07-08 成都优洛生物科技有限公司 一种重组cho细胞、其构建方法、利用其的检测系统和方法
CN115894705A (zh) * 2021-09-30 2023-04-04 三生国健药业(上海)股份有限公司 一种β-NGF融合蛋白、其制备方法及用途

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK161152C (da) * 1983-03-03 1991-11-11 Genentech Inc Polypeptid med egenskaber som human beta-nervevaekstfaktor og fremgangsmaade til fremstilling deraf, dna-isolat omfattende en sekvens som koder for polypeptidet, replicerbar udtrykkelsesvektor for dna-sekvensen, rekombinant vaertscelle transformeret med vektoren, farmaceutisk praeparat indeholdende polypeptidet og fremg. der omfatter anvendelsen af polypeptidet til fremst. af et farmaceutisk praeparat
US4796580A (en) * 1987-09-11 1989-01-10 Allied-Signal Inc. Idle control valve for use with a throttle assembly of an internal combustion engine
JPH01211490A (ja) * 1988-02-19 1989-08-24 Tosoh Corp ヒト神経成長因子遺伝子セグメント
US5272063A (en) * 1988-11-22 1993-12-21 Syntex (U.S.A.) Inc. Process of making human nerve growth factor

Also Published As

Publication number Publication date
IT8948564A0 (it) 1989-11-16
ES2173856T3 (es) 2002-11-01
HU907174D0 (en) 1991-05-28
DE69033937D1 (de) 2002-04-25
AU6655890A (en) 1991-05-23
ZA909122B (en) 1991-09-25
JPH03224490A (ja) 1991-10-03
IT1238348B (it) 1993-07-13
TW205069B (es) 1993-05-01
PT95911A (pt) 1991-09-13
NZ236058A (en) 1993-04-28
PT95911B (pt) 1998-01-30
IL96347A (en) 1997-11-20
FI905691A (fi) 1991-05-17
EP0432510A1 (en) 1991-06-19
IT8948564A1 (it) 1991-05-16
JP2001000194A (ja) 2001-01-09
DE69033937T2 (de) 2002-11-14
YU217890A (sh) 1993-05-28
AU645998B2 (en) 1994-02-03
EP0432510B1 (en) 2002-03-20
IL96347A0 (en) 1991-08-16
FI905691A0 (fi) 1990-11-16
IE904120A1 (en) 1991-05-22
HUT61047A (en) 1992-11-30
CA2030108C (en) 1998-04-28
ATE214735T1 (de) 2002-04-15
JP3121611B2 (ja) 2001-01-09
PL287811A1 (en) 1991-12-02
CN1051934A (zh) 1991-06-05
KR910009929A (ko) 1991-06-28
AR246983A1 (es) 1994-10-31
CA2030108A1 (en) 1991-05-17
US5457034A (en) 1995-10-10

Similar Documents

Publication Publication Date Title
PE28191A1 (es) Procedimiento para la expresion del factor de crecimiento nervioso en celulas eucarioticas
ES2093025T3 (es) Produccion del factor de crecimiento de celulas endoteliales y adn de codificacion del mismo.
ES2094159T3 (es) Produccion de factor de crecimiento de celulas endoteliales vasculares.
ATE169956T1 (de) Dna, die für proteine kodiert, die menschliches il-1 binden
DE10075011I2 (de) Rezeptoren für Tumornekrosisfaktor-alpha und-beta.
ES2073327T3 (es) Gen y proteina inducida por tgf-beta.
ES533054A0 (es) Un metodo para producir un gen que contiene una muteina sintetica de una proteina biologicamente activa
ES2037083T3 (es) Gen de eritropoietina: expresion de alto nivel en celulas de mamiferos transfectadas de forma estable.
PT81590B (pt) Metodo para a producao de um clone de cdna humanoque exprime eritropoietina biologicamente activa
DE3752319D1 (de) Prozess zur rekombinanten Herstellung von HIV-2 - Proteinen sowie Zellen, die HIV-2 - Proteine exprimiert
ATE123065T1 (de) Proteine und deren herstellung.
PT1318198E (pt) Processo para produzir um polipeptido recombinante que envolve a adicao de um inibidor de quimotripsina ao meio de cultura celular
DE69016508D1 (de) Interleukin-7-Rezeptoren.
EP0835661A3 (en) Human interferon-Beta2A for use as a medicament
ES2101716T3 (es) Vectores y compuestos para la expresion de mutantes de glicosilacion de la proteina c humana.
ATE282691T1 (de) Chemokin typ cc-ahnliches protein
DE3880032D1 (de) Expressionsvektoren fuer die produktion von humanem gm-csf in saengerzellen.
FI904789A0 (fi) Menetelmä terapeuttisesti käyttökelpoisen, olennaisesti puhtaan polypeptidin valmistamiseksi
MX9203409A (es) Proteinas bcrfi como inhibidores de la gama interferona.
DE69033987D1 (de) Katze-Maus-Heterohybridoma und Genfragment, das für die Konstant-Region von Katze-Immunoglobulin codiert
ES2061719T3 (es) Proceso para la produccion de proteinas.
BR9404991A (pt) Processos para aumentar a produção de proteína C e para aumentar o nível de gama-carboxiliação de uma molécula de proteína C
DE69027466D1 (de) Achromobacter-Protease-I-Gen sowie Genprodukt
ATA435083A (de) Das polypeptid interleukin-2 kodierendes gen, rekombinante, dieses gen enthaltende dna, diese rekombinante dna aufweisende zellinien und verfahren zur herstellung von interleukin-2 unter verwendung der genannten zellen
ES2136199T3 (es) Expresion multicistronica de genes recombinantes en celulas bacterianas.